Key result
In the first 6 American implants, initial outcomes suggest the DuraHeart left ventricular assist system is safe and effective for advanced heart failure.
Why the study?
Is the Terumo DuraHeart left ventricular assist system safe and effective for patients with advanced heart failure?
Case Report (n=6)
Is the Terumo DuraHeart left ventricular assist system safe and effective for patients with advanced heart failure?
The initial American experience with the Terumo DuraHeart LVAS suggests it is a safe and effective option for advanced heart failure patients.
Answers are grounded in this paper and cite their sources.
Case series of DuraHeart LVAS is hypothesis-generating; larger prospective trials needed before clinical adoption.
Since the first implantation of a left ventricular assist system (LVAS) 45 years ago, LVAS therapy has emerged as a viable option for the treatment of advanced heart failure. The current generation of LVASs in clinical evaluation has design features enabling longer and more reliable support durations. We describe the operating characteristics of the DuraHeart LVAS (Terumo Heart, Inc., Ann Arbor, MI). The DuraHeart LVAS is a magnetically-levitated centrifugal pump that began a FDA-approved clinical trial for evaluation of bridge to transplant indication in July of 2008. Magnetic levitation of the spinning-pump impeller is hypothesized to improve long-term mechanical reliability and biological compatibility of the pump. Other design features make the DuraHeart LVAS particularly suited for implantation without cardiopulmonary bypass (CPB). A description of the implant procedure for the first six American implants of the DuraHeart LVAS both on-CPB and off-CPB, including CPB techniques employed, are discussed. While it is still very early in the DuraHeart LVAS experience, the initial outcomes of the first six patient implants would suggest that the device is a safe and effective LVAS.
No takes yet. Share an insight, caveat, or question.
Griffith et al. (2009) conducted a case report in Advanced heart failure (n=6). Terumo DuraHeart left ventricular assist system was evaluated on Safety and effectiveness. In the first 6 American implants, initial outcomes suggest the DuraHeart left ventricular assist system is safe and effective for advanced heart failure.
Synapse has enriched 10 related papers. Consider them for comparative context: